Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT|[sol]|BR9601 trials

H M Earl; L Hiller; J A Dunn; A-L Vallier; S J Bowden; S D Jordan; F Blows; A Munro; S Bathers; R Grieve; D A Spooner; R Agrawal; I Fernando; A M Brunt; S M OReilly; S M Crawford; D W Rea; P Simmonds; J L Mansi; A Stanley; K McAdam; L Foster; R CF Leonard; C J Twelves; D Cameron; J MS Bartlett; P Pharoah; E Provenzano; C Caldas; C J Poole

首页> 外文期刊>British Journal of Cancer >Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT|[sol]|BR9601 trials

【24h】

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT|[sol]|BR9601 trials

机译：早期乳腺癌的佐比表柔比星联合环磷酰胺，甲氨蝶呤和氟尿嘧啶（CMF）与CMF的比较：NEAT | [sol] | BR9601随机III期试验的中位随访时间超过7年

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background:The National Epirubicin Adjuvant Trial (NEAT) and BR9601 trials tested the benefit of epirubicin when added to cyclophosphamide, methotrexate and 5-fluorouracil (E-CMF) compared with standard CMF in adjuvant chemotherapy for women with early breast cancer. This report details longer follow-up with interesting additional time-dependent analyses.

机译：背景：美国国家表柔比星佐剂试验（NEAT）和BR9601试验测试了将表柔比星与环丙酰胺，甲氨蝶呤和5-氟尿嘧啶（E-CMF）相比，在早期乳腺癌女性辅助化疗中与标准CMF相比的益处。该报告详细介绍了更长的随访时间，并进行了有趣的其他随时间变化的分析。

著录项

来源
《British Journal of Cancer》 |2012年第8期|共11页
作者
H M Earl; L Hiller; J A Dunn; A-L Vallier; S J Bowden; S D Jordan; F Blows; A Munro; S Bathers; R Grieve; D A Spooner; R Agrawal; I Fernando; A M Brunt; S M OReilly; S M Crawford; D W Rea; P Simmonds; J L Mansi; A Stanley; K McAdam; L Foster; R CF Leonard; C J Twelves; D Cameron; J MS Bartlett; P Pharoah; E Provenzano; C Caldas; C J Poole;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT|[sol]|BR9601 trials [J] . H M Earl, L Hiller, J A Dunn, British Journal of Cancer . 2012,第8期

机译：早期乳腺癌的佐比表柔比星联合环磷酰胺，甲氨蝶呤和氟尿嘧啶（CMF）与CMF的比较：NEAT | [sol] | BR9601随机III期试验的中位随访时间超过7年
2. Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer. [J] . Amadori D, Silvestrini R, De Lena M, Breast cancer research and treatment. . 2011,第3期

机译：在淋巴结阴性或1-3淋巴结阳性的快速增生乳腺癌患者中，进行佐剂表柔比星，环磷酰胺，甲氨蝶呤和5-氟尿嘧啶（CMF）与CMF联合表柔比星的III期随机试验。
3. Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer [J] . Dino Amadori, Rosella Silvestrini, Mario De Lena, Breast Cancer Research and Treatment . 2011,第3期

机译：淋巴结阴性或1-3淋巴结阳性迅速增生的乳腺癌患者的佐比表柔比星，环磷酰胺，甲氨蝶呤和5-氟尿嘧啶（CMF）与CMF联合表柔比星的III期随机试验
4. Use of Laser Photomodulation in the Evolution of Oral Mucositis Associated to Cyclophosphamide, Methotrexate, 5-Fluouracil - CMF in 5 Fluouracil + Adriamycin + Cyclophosphamide - FAC Chemotherapy Protocols in Patients with Breast Cancer [C] . Maria de Fatima Lima Ferreira, Fabiola Bastos de Carvalho, Susana C. P. S. de Oliveira, Mechanisms for low-light therapy VIII . 2013

机译：激光光调节在5种氟尿嘧啶+阿霉素+环磷酰胺-FAC化疗方案中与环磷酰胺，甲氨蝶呤，5-氟尿嘧啶-CMF相关的口腔黏膜演变中的应用
5. Adjuvant epirubicin followed by cyclophosphamide methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials [O] . H M Earl, L Hiller, J A Dunn, 2012

机译：早期乳腺癌的佐比表柔比星环磷酰胺氨甲蝶呤和氟尿嘧啶（CMF）与CMF的比较：来自随机III期NEAT / BR9601试验的中位随访7年以上的结果
6. Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer:results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials [O] . Earl, H. M., Hiller, L., Dunn, J. A., 2012

机译：在早期乳腺癌中佐剂表柔比星，环磷酰胺，甲氨蝶呤和氟尿嘧啶（CMF）与CMF的比较：NEAT / BR9601随机III期试验的中位随访时间超过7年

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT|[sol]|BR9601 trials

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅